Dr. Mora is a cardiologist and molecular epidemiologist conducting translational research in the prevention of cardiometabolic disease, with a focus on lipid and inflammatory mechanisms of cardiovascular disease. She is a Professor of Medicine at Harvard Medical School and the Director of the Center for Lipid Metabolomics, Divisions of Preventive and Cardiovascular Medicine at the Brigham and Women’s Hospital, Boston, Massachusetts. Dr. Mora is board certified in cardiovascular disease and echocardiography, and serves on the Editorial Boards of JAMA Internal Medicine and Atherosclerosis. She is an Elected Member of the American Society for Clinical Investigation and the Association of University Cardiologists.

Dr. Mora has sources of funding and relationships with the following commercial stakeholders in the healthcare sector:
• Pfizer (consultant).